FOLD
Price
$14.29
Change
+$0.01 (+0.07%)
Updated
Feb 5, 02:54 PM (EDT)
Capitalization
4.48B
14 days until earnings call
Intraday BUY SELL Signals
INBX
Price
$82.94
Change
+$0.38 (+0.46%)
Updated
Feb 5, 03:09 PM (EDT)
Capitalization
1.2B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FOLD vs INBX

Header iconFOLD vs INBX Comparison
Open Charts FOLD vs INBXBanner chart's image
Amicus Therapeutics
Price$14.29
Change+$0.01 (+0.07%)
Volume$7.43K
Capitalization4.48B
Inhibrx Biosciences
Price$82.94
Change+$0.38 (+0.46%)
Volume$200
Capitalization1.2B
FOLD vs INBX Comparison Chart in %
View a ticker or compare two or three
VS
FOLD vs. INBX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and INBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (FOLD: $14.27 vs. INBX: $82.56)
Brand notoriety: FOLD and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 71% vs. INBX: 76%
Market capitalization -- FOLD: $4.48B vs. INBX: $1.2B
FOLD [@Biotechnology] is valued at $4.48B. INBX’s [@Biotechnology] market capitalization is $1.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 1 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 1 green, 4 red.
According to our system of comparison, INBX is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 3 TA indicator(s) are bullish while INBX’s TA Score has 4 bullish TA indicator(s).

  • FOLD’s TA Score: 3 bullish, 4 bearish.
  • INBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both FOLD and INBX are a bad buy in the short-term.

Price Growth

FOLD (@Biotechnology) experienced а -0.07% price change this week, while INBX (@Biotechnology) price change was +11.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

FOLD is expected to report earnings on Feb 19, 2026.

INBX is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($4.48B) has a higher market cap than INBX($1.2B). INBX YTD gains are higher at: 4.506 vs. FOLD (0.211). FOLD has higher annual earnings (EBITDA): 59.3M vs. INBX (-143.46M). FOLD has more cash in the bank: 264M vs. INBX (153M). INBX has less debt than FOLD: INBX (107M) vs FOLD (443M). FOLD has higher revenues than INBX: FOLD (599M) vs INBX (1.4M).
FOLDINBXFOLD / INBX
Capitalization4.48B1.2B372%
EBITDA59.3M-143.46M-41%
Gain YTD0.2114.5065%
P/E RatioN/A0.20-
Revenue599M1.4M42,786%
Total Cash264M153M173%
Total Debt443M107M414%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDINBX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 23 days ago
71%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
FOLD
Daily Signal:
Gain/Loss:
INBX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEIRX97.701.07
+1.11%
Vanguard Equity-Income Adm
DEVIX73.750.74
+1.01%
Nomura Small Cap Value Institutional
JNPSX25.480.25
+0.99%
Janus Henderson Small Cap Value D
IEYCX10.980.05
+0.46%
Nomura Climate Solutions C
SAGAX53.50-2.41
-4.31%
Virtus Zevenbergen Innovative Gr Stk A

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been closely correlated with ACET. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if FOLD jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.07%
ACET - FOLD
80%
Closely correlated
-3.51%
GPCR - FOLD
76%
Closely correlated
-3.01%
PHGE - FOLD
75%
Closely correlated
-7.36%
INBX - FOLD
74%
Closely correlated
-2.96%
PMN - FOLD
73%
Closely correlated
-1.57%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been closely correlated with ACET. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if INBX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-2.96%
ACET - INBX
86%
Closely correlated
-3.51%
TERN - INBX
82%
Closely correlated
-6.39%
ERAS - INBX
80%
Closely correlated
+6.19%
PRAX - INBX
79%
Closely correlated
-2.31%
CANF - INBX
79%
Closely correlated
-0.25%
More